{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:01:19Z","timestamp":1773885679854,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012416","name":"INOVA Health Care Services Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","award":["RC: 31-4710832"],"award-info":[{"award-number":["RC: 31-4710832"]}],"id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.obpill.2025.100240","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:26:45Z","timestamp":1764923205000},"page":"100240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Applicability of the New Zealand-eating behavior questionnaire to predict weight loss responses to naltrexone\/bupropion: a proof-of-concept trial"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2569-4216","authenticated-orcid":false,"given":"Ole","family":"Schmiedel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-5108","authenticated-orcid":false,"given":"Melissa","family":"Ivey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishi","family":"Karunasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0043-2423","authenticated-orcid":false,"given":"Rinki","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2025.100240_bib1","first-page":"221","article-title":"Definition and diagnostic criteria of clinical obesity, the lancet","volume":"13","author":"Rubino","year":"2025","journal-title":"Diabetes Endocrinol"},{"key":"10.1016\/j.obpill.2025.100240_bib2","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.2337\/dc25-S008","article-title":"8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in Diabetes\u20132025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100240_bib3","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1002\/oby.22154","article-title":"The accumulating data to optimally predict obesity treatment (ADOPT) core measures project: rationale and approach","volume":"26","author":"MacLean","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.obpill.2025.100240_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.obpill.2025.100240_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/oby.23120","article-title":"Selection of obesity medications based on phenotypes enhances weight loss: a pragmatic trial in an obesity clinic","volume":"29","author":"Acosta","year":"2021","journal-title":"Obesity"},{"key":"10.1016\/j.obpill.2025.100240_bib6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/ijo.2016.67","article-title":"The relationship between early weight loss and weight loss at 1 year with naltrexone ER\/bupropion ER combination therapy","volume":"40","author":"Fujioka","year":"2016","journal-title":"Int J Obes"},{"key":"10.1016\/j.obpill.2025.100240_bib7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/archinte.165.15.1749","article-title":"The role of patient-physician trust in moderating medication nonadherence due to cost pressures","volume":"165","author":"Piette","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.obpill.2025.100240_bib8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1053\/j.gastro.2016.12.049","article-title":"Practical use of pharmacotherapy for obesity","volume":"152","author":"Igel","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.obpill.2025.100240_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.eprac.2023.02.001","article-title":"American association of clinical endocrinology consensus statement: comprehensive type 2 diabetes management algorithm \u2013 2023 update","volume":"29","author":"Samson","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/j.obpill.2025.100240_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/j.gastro.2014.11.020","article-title":"Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy","volume":"148","author":"Acosta","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.obpill.2025.100240_bib11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.cmet.2025.05.008","article-title":"Genetic and physiological insights into satiation variability predict responses to obesity treatment","volume":"37","author":"Cifuentes","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.obpill.2025.100240_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2023.107066","article-title":"The New Zealand eating behavior questionnaire \u2013 validation study for a novel assessment tool to describe actionable eating behavior traits","volume":"191","author":"Schmiedel","year":"2023","journal-title":"Appetite"},{"key":"10.1016\/j.obpill.2025.100240_bib13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/nu17061049","article-title":"Broader validation of New Zealand eating behavior questionnaire as clinical assessment tool to identify actionable eating behavior traits","volume":"17","author":"Schmiedel","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100240_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/156482650602700207","article-title":"Evidence-based nutrition recommendations for the treatment and prevention of type 2 diabetes and the metabolic syndrome","volume":"27","author":"Mann","year":"2006","journal-title":"Food Nutr Bull"},{"key":"10.1016\/j.obpill.2025.100240_bib15","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/oby.20408","article-title":"Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model, obesity","volume":"21","author":"Thomas","year":"2013","journal-title":"Silver Spring, Md)"},{"key":"10.1016\/j.obpill.2025.100240_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40290-023-00503-w","article-title":"The importance of assessing drug exposure and medication adherence in evaluating investigational medications: ensuring validity and reliability of clinical trial results","volume":"38","author":"Vrijens","year":"2024","journal-title":"Pharm Med"},{"key":"10.1016\/j.obpill.2025.100240_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s11154-021-09700-x","article-title":"Interactions between emotions and eating behaviors: main issues, neuroimaging contributions, and innovative preventive or corrective strategies","volume":"23","author":"Godet","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.obpill.2025.100240_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.physbeh.2018.02.011","article-title":"Homeostatic and non-homeostatic controls of feeding behavior: distinct vs. common neural systems","volume":"193","author":"Liu","year":"2018","journal-title":"Physiol Behav"},{"key":"10.1016\/j.obpill.2025.100240_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1467-789X.2010.00714.x","article-title":"Appetite control: methodological aspects of the evaluation of foods","volume":"11","author":"Blundell","year":"2010","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100240_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T","article-title":"The dutch eating behavior questionnaire (DEBQ) for assessment of restrained, emotional, and external eating behavior","volume":"5","author":"Van Strien","year":"1986","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.obpill.2025.100240_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-3999(85)90010-8","article-title":"The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger","volume":"29","author":"Stunkard","year":"1985","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.obpill.2025.100240_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5868-6-41","article-title":"Three factor eating questionnaire-R18 as a measure of cognitive restraint, uncontrolled eating and emotional eating in a sample of young Finnish females","volume":"6","author":"Angl\u00e9","year":"2009","journal-title":"Int J Behav Nutr Phys Activ"},{"key":"10.1016\/j.obpill.2025.100240_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1098-108X(199909)26:2<195::AID-EAT9>3.0.CO;2-2","article-title":"Evaluating direct and indirect measures for the functional assessment of binge eating","volume":"26","author":"Stickney","year":"1999","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.obpill.2025.100240_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/erv.2515","article-title":"Development of the modified yale food addiction scale version 2.0","volume":"25","author":"Schulte","year":"2017","journal-title":"Eur Eat Disord Rev"},{"key":"10.1016\/j.obpill.2025.100240_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fpsyg.2014.00190","article-title":"A short version of the food cravings questionnaire-trait: the FCQ-T-reduced","volume":"5","author":"Meule","year":"2014","journal-title":"Front Psychol"},{"key":"10.1016\/j.obpill.2025.100240_bib26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.appet.2016.05.024","article-title":"Appetitive traits and relationships with BMI in adults: development of the adult eating behaviour questionnaire","volume":"105","author":"Hunot","year":"2016","journal-title":"Appetite"},{"key":"10.1016\/j.obpill.2025.100240_bib27","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s40519-022-01363-0","article-title":"Development, validation and clinical use of the eating behaviors assessment for obesity (EBA-O)","volume":"27","author":"Segura-Garcia","year":"2022","journal-title":"Eat Weight Disord"},{"key":"10.1016\/j.obpill.2025.100240_bib28","first-page":"164","article-title":"Naltrexone\/bupropion ER (contrave): newly approved treatment option for chronic weight management in Obese adults","volume":"41","author":"Sherman","year":"2016","journal-title":"P T"},{"key":"10.1016\/j.obpill.2025.100240_bib29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ijo.2013.145","article-title":"Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues","volume":"38","author":"Wang","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/j.obpill.2025.100240_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.appet.2007.07.002","article-title":"How emotions affect eating: a five-way model","volume":"50","author":"Macht","year":"2008","journal-title":"Appetite"},{"key":"10.1016\/j.obpill.2025.100240_bib31","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1093\/cercor\/bhaa147","article-title":"Emotion regulation modulates dietary decision-making via activity in the prefrontal\u2013striatal valuation system","volume":"30","author":"Morawetz","year":"2020","journal-title":"Cerebr Cortex"},{"key":"10.1016\/j.obpill.2025.100240_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/obr.12329","article-title":"Association between emotions and eating behaviour in an Obese population with binge eating disorder","volume":"17","author":"Nicholls","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100240_bib33","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJM199005243222102","article-title":"The body-mass index of twins who have been reared apart","volume":"322","author":"Harris","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100240_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/19485565.2013.774628","article-title":"Development and evaluation of a genetic risk score for obesity","volume":"59","author":"Belsky","year":"2013","journal-title":"Biodemogr Soc Biol"},{"key":"10.1016\/j.obpill.2025.100240_bib35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jamapediatrics.2013.4944","article-title":"Satiety mechanisms in genetic risk of obesity","volume":"168","author":"Llewellyn","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.obpill.2025.100240_bib36","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity\u2010related risk factors (COR\u2010II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.obpill.2025.100240_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.obpill.2025.100240_bib38","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.2337\/dc13-0234","article-title":"Effects of naltrexone Sustained- release\/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and Obese patients with type 2 diabetes","volume":"36","author":"Hollander","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100240_bib39","article-title":"The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy","volume":"49","author":"le Roux","year":"2022","journal-title":"eClin Med"},{"key":"10.1016\/j.obpill.2025.100240_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/pst.477","article-title":"A guide to the design and analysis of small clinical studies","volume":"10","author":"Kianifard","year":"2011","journal-title":"Pharm Stat: J Pharm Indust"},{"key":"10.1016\/j.obpill.2025.100240_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2288-14-41","article-title":"The statistical interpretation of pilot trials: should significance thresholds be reconsidered?","volume":"14","author":"Lee","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.obpill.2025.100240_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s13679-018-0301-3","article-title":"Racial disparities in obesity treatment","volume":"7","author":"Byrd","year":"2018","journal-title":"Curr Obes Rep"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368125000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368125000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:42:34Z","timestamp":1773866554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368125000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"alternative-id":["S2667368125000841"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2025.100240","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applicability of the New Zealand-eating behavior questionnaire to predict weight loss responses to naltrexone\/bupropion: a proof-of-concept trial","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2025.100240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100240"}}